The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently ...
Immunovant (NASDAQ:IMVT – Get Free Report) had its price target dropped by equities researchers at Guggenheim from $46.00 to ...
Thyrocare founder Dr. A. Velumani recently shared an encounter with a Mumbai auto driver whose son is studying at IIT ...
Even as researchers are trying to understand the phenomenon, India’s community health workers are acting as an early warning ...
In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.
Just because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...